The Company of Biologists has announced the appointment of Dan Shanahan as its new Chief Executive Officer, effective September 14, 2026.
Shanahan brings extensive experience in scholarly publishing and open science initiatives, having held leadership roles at Springer Nature, F1000, Cochrane, and most recently as Publishing Director at PLOS. His background in open access publishing and nonprofit leadership is expected to support the organization’s mission to advance biology and inspire the global biological community.
Sarah Bray, Chair of the Board of Directors at The Company of Biologists, stated that Shanahan’s appointment reflects the organization’s commitment to building a sustainable future. She noted that his experience in developing networks within the scholarly publishing landscape, combined with his vision and enthusiasm, aligns with the company’s long‑term goals of supporting biologists and inspiring biology.
The Company of Biologists works across all areas of biology through journals, grants, and events, aiming to provide accessible content for researchers and to strengthen community engagement.
Shanahan expressed that joining The Company of Biologists offers an opportunity to contribute to an organization with a unique position in the biological sciences. He emphasized the importance of building on its legacy, exploring new opportunities, and supporting the wider scientific community through its journals and charitable activities.
He succeeds Claire Moulton, who retired from the role of Chief Executive Officer at the end of July 2026.
Click here to read the original press release.
